A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth

NCT00069004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2014-01-07

No results posted yet for this study

Summary

The purpose of this study is to assess the prevalence of metabolic and physical abnormalities in HIV infected (via mother-to-child transmission) and uninfected children and youth. Metabolism, body composition, bone density, and other factors will be assessed in relationship to participants' exposure to highly active antiretroviral therapy (HAART).

Conditions

  • HIV Infections
  • HIV-Associated Lipodystrophy Syndrome
  • HIV Lipodystrophy Syndrome
  • Lipodystrophy
  • Dyslipidemia
  • Osteoporosis
  • Osteopenia

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH
  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Grace Aldrovandi, MD · University of Alabama at Birmingham

  • Peggy Borum, PhD · University of Florida

Eligibility

Min Age
7 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-10-31
Completion
2005-08-31

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00069004 on ClinicalTrials.gov